Correlation Between Maat Pharma and SQLI SA
Can any of the company-specific risk be diversified away by investing in both Maat Pharma and SQLI SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maat Pharma and SQLI SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maat Pharma SA and SQLI SA, you can compare the effects of market volatilities on Maat Pharma and SQLI SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maat Pharma with a short position of SQLI SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maat Pharma and SQLI SA.
Diversification Opportunities for Maat Pharma and SQLI SA
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Maat and SQLI is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Maat Pharma SA and SQLI SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SQLI SA and Maat Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maat Pharma SA are associated (or correlated) with SQLI SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SQLI SA has no effect on the direction of Maat Pharma i.e., Maat Pharma and SQLI SA go up and down completely randomly.
Pair Corralation between Maat Pharma and SQLI SA
If you would invest 782.00 in Maat Pharma SA on September 27, 2024 and sell it today you would earn a total of 12.00 from holding Maat Pharma SA or generate 1.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 59.09% |
Values | Daily Returns |
Maat Pharma SA vs. SQLI SA
Performance |
Timeline |
Maat Pharma SA |
SQLI SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Maat Pharma and SQLI SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Maat Pharma and SQLI SA
The main advantage of trading using opposite Maat Pharma and SQLI SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maat Pharma position performs unexpectedly, SQLI SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SQLI SA will offset losses from the drop in SQLI SA's long position.Maat Pharma vs. LVMH Mot Hennessy | Maat Pharma vs. Manitou BF SA | Maat Pharma vs. Memscap Regpt | Maat Pharma vs. Poxel SA |
SQLI SA vs. Sopra Steria Group | SQLI SA vs. Manitou BF SA | SQLI SA vs. Memscap Regpt | SQLI SA vs. Maat Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |